Suzetrigine (VX-548) exhibits activity-dependent effects on human dorsal root ganglion neurons
Uhelski, M. L.; Schaub, M. K.; Espinosa, F.; Heles, M.; Cortes-Mejia, N. A.; Li, Y.; Tatsui, C. E.; Rhines, L. D.; Alvarez-Breckendridge, C.; Funk, G.; Horton, P.; Cervantes, A.; Lesnak, J. B.; Curatolo, M.; Dussor, G.; Price, T. J.; Dougherty, P. M. M.
Show abstract
Non-selective antagonists of voltage-gated sodium channels (VGSCs) provide effective local analgesia, but systemic administration is fraught with unwanted cardiovascular and central nervous system toxicity. The development of antagonists targeting VGSCs preferentially expressed in peripheral neurons, such as NaV1.7, 1.8, and 1.9, could mitigate these risks. One such new small molecule that selectively inhibits NaV1.8, is orally bioavailable, and has recent FDA approval for the treatment of acute pain is suzetrigine (VX-548). Here we tested the effects of this agent on human dorsal root ganglion (hDRG) neurons obtained from either patients undergoing surgical thoracic vertebrectomy or from organ donors in parallel electrophysiology studies across 2 laboratories. Bath application of 10 nM suzetrigine abolished spontaneous discharges previously shown to be associated with on-going neuropathic pain within minutes. In contrast, suppression of discharges evoked by intracellular current injection required more prolonged application times. These results suggest that suzetrigine will likely show efficacy versus spontaneous pain but may have less robust effects on evoked or breakthrough pain.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Bradykinin receptor expression and bradykinin-mediated sensitization of human sensory neurons 96%
- Readiness of nociceptor cell bodies to generate spontaneous activity results from background activity of diverse ion channels and high input resistance 96%
- Examination of the contribution of Nav1.7 to axonal propagation in nociceptors 96%
Similar papers in this journal
- The Secretomes of Painful Versus Nonpainful Human Schwannomatosis Tumor Cells Differentially Influence Sensory Neuron Gene Expression and Sensitivity 95%
- Calretinin-expressing islet cells: a source of pre- and post-synaptic inhibition of non-peptidergic nociceptor input to the mouse spinal cord 95%
- Identification of Sensory Fiber Types in Mouse Temporomandibular Joint Tissues 94%
Similar papers in this journal
- Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain 96%
- Neuropeptide Y-expressing dorsal horn inhibitory interneurons gate spinal pain and itch signalling 95%
- Computational design of peptides to target Nav1.7 channel with high potency and selectivity for the treatment of pain 94%
Similar papers in this journal
- De novo expression of neuropeptide Y in sensory neurons does not contribute to peripheral neuropathic pain 95%
- The delta-opioid receptor bidirectionally modulates itch 95%
- Protease-Activated Receptor 2 (PAR2) expressed in sensory neurons contributes to signs of pain and neuropathy in paclitaxel treated mice 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.